[
    "{\"step_by_step_thinking\": \"Galcanezumab is a monoclonal antibody that targets calcitonin gene-related peptide (CGRP), a molecule that is involved in migraine attacks. Several clinical trials have shown that galcanezumab can reduce the frequency of migraine attacks in patients. Therefore, it is considered effective for the treatment of migraine.\", \"answer_choice\": \"A\"}"
]